Methotrexate vs 6‐MP or azathioprine
Adverse events (Ardizzone 2003) · adult patients with refractory Crohn's disease
It is very uncertain whether methotrexate changes adverse events (Ardizzone 2003) compared with 6‐MP or azathioprine (very low certainty).
1 finding from 1 review
- Methotrexate for induction of remission in refractory Crohn's disease 2014 · Cochrane Headline outcomes onlyRR 2.43 [1.21, 4.89]1 study · 54 participantsVery low